Human Genome Epidemiology Literature Finder
|
Records 1 - 28 (of 28 Records) |
| Query Trace: Breast Neoplasms and SLCO1B1[original query] |
|---|
| Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clinica chimica acta; international journal of clinical chemistry 2006 Nov 373 (1-2): 99-103. Zhang Wei, Yu Bang-Ning, He Yi-Jing, Fan Lan, Li Qing, Liu Zhao-Qian, Wang An, Liu Ya-Li, Tan Zhi-Rong, Fen-Jiang , Huang Yuan-Fei, Zhou Hong-H |
| Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants. Pharmacogenetics and genomics 2007 Aug 17 (8): 647-56. Ho Richard H, Choi Leena, Lee Wooin, Mayo Gail, Schwarz Ute I, Tirona Rommel G, Bailey David G, Michael Stein C, Kim Richard |
| Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Therapeutic drug monitoring 2008 Oct 30 (5): 559-64. Miura Masatomo, Kagaya Hideaki, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
| Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers. Xenobiotica; the fate of foreign compounds in biological systems 2010 Nov 40 (11): 782-9. Akamine Yumiko, Miura Masatomo, Sunagawa Satoko, Kagaya Hideaki, Yasui-Furukori Norio, Uno Tsuka |
| Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
| Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study. Circulation. Cardiovascular genetics 2010 Jun 3 (3): 276-85. Bailey Kristian M, Romaine Simon P R, Jackson Beryl M, Farrin Amanda J, Efthymiou Maria, Barth Julian H, Copeland Joanne, McCormack Terry, Whitehead Andrew, Flather Marcus D, Samani Nilesh J, Nixon Jane, Hall Alistair S, Balmforth Anthony J, |
| The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort. Breast cancer research : BCR 2011 13 (2): R37. Lee Eunjung, Schumacher Fredrick, Lewinger Juan Pablo, Neuhausen Susan L, Anton-Culver Hoda, Horn-Ross Pamela L, Henderson Katherine D, Ziogas Argyrios, Van Den Berg David, Bernstein Leslie, Ursin Gis |
| Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan. Journal of cardiovascular pharmacology 2012 Jul 60 (1): 49-54. Kim Choon O, Cho Sung K, Oh Eun S, Park Min S, Chung Jae-Yo |
| SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study. BMC cancer 2016 16 (1): 337. Reimer Toralf, Kempert Sarah, Gerber Bernd, Thiesen Hans-Jürgen, Hartmann Steffi, Koczan Di |
| Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis. Clinical pharmacokinetics 2017 Jun . Li Rui, Barton Hugh |
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Breast cancer research and treatment 2017 Apr . Dudenkov Tanda M, Ingle James N, Buzdar Aman U, Robson Mark E, Kubo Michiaki, Ibrahim-Zada Irada, Batzler Anthony, Jenkins Gregory D, Pietrzak Tracy L, Carlson Erin E, Barman Poulami, Goetz Matthew P, Northfelt Donald W, Moreno-Aspita Alvaro, Williard Clark V, Kalari Krishna R, Nakamura Yusuke, Wang Liewei, Weinshilboum Richard |
| Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat. Journal of clinical pharmacology 2019 Aug . Willis Brian A, Andersen Scott W, Ayan-Oshodi Mosun, James Douglas E, Liffick Emily, Hillgren Kathleen, Guo Yingying, Monk Scott |
| Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole. Pharmacogenomics 2019 6 20 (8): 571-580. Dempsey Jacqueline M, Kidwell Kelley M, Gersch Christina L, Pesch Andrea M, Desta Zeruesenay, Storniolo Anna Maria, Stearns Vered, Skaar Todd C, Hayes Daniel F, Henry N Lynn, Rae James M, Hertz Daniel |
| Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies. Journal of clinical pharmacology 2019 Apr . Kobie Julie, Guo Zifang, Cho Carolyn R, Menzel Karsten, McCrea Jacqueline B, Blanchard Rebecca, Shaw Peter |
| Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer. Pharmacogenomics 2019 Feb . Kamio Hidenori, Uchiyama Toshitaka, Kanno Hitoshi, Onoe Yoshiko, Saito Kayoko, Kameoka Shingo, Kamio Takako, Okamoto Takahi |
| Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Feb 28 (2): 265-274. Chang Huiru, Yao Song, Tritchler David, Hullar Meredith A, Lampe Johanna W, Thompson Lilian U, McCann Susan |
| Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. Scientific reports 2019 12 9 (1): 19410. Kim Yun, Yoon Seonghae, Choi Yewon, Yoon Seo Hyun, Cho Joo-Youn, Jang In-Jin, Yu Kyung-Sang, Chung Jae-Yo |
| Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin. Acta oncologica (Stockholm, Sweden) 2020 5 59 (9): 1009-1015. Ahern Thomas P, Damkier Per, Feddersen Søren, Kjærsgaard Anders, Lash Timothy L, Hamilton-Dutoit Stephen, Lythjohan Cathrine Bredal, Ejlertsen Bent, Christiansen Peer M, Cronin-Fenton Deirdre |
| SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population. Pharmacogenomics and personalized medicine 2020 10 13 521-530. Rattanacheeworn Punyabhorn, Chamnanphon Monpat, Thongthip Siriwan, Kittanamongkolchai Wonngarm, Townamchai Natavudh, Avihingsanon Yingyos, Udomnilobol Udomsak, Prueksaritanont Thomayant, Jianmongkol Suree, Chariyavilaskul Pajar |
| Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
| Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes. European journal of clinical pharmacology 2021 1 77 (8): 1095-1111. Wang Tingyu, Zhou Yitian, Cao Guoshe |
| An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer. Frontiers in pharmacology 2022 8 13 897951. Roncato Rossana, Gerratana Lorenzo, Palmero Lorenza, Gagno Sara, Poetto Ariana Soledad, Peruzzi Elena, Zanchetta Martina, Posocco Bianca, De Mattia Elena, Canil Giovanni, Alberti Martina, Orleni Marco, Toffoli Giuseppe, Puglisi Fabio, Cecchin Eri |
| Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis. Clinical and translational science 2022 Jul . Guijosa Alberto, Freyria Ana, Espinosa-Fernandez Jose Rodrigo, Estrada-Mena Francisco J, Armenta-Quiroga Ana Sofía, Ortega-Treviño Maria Fernanda, Catalán Rodrigo, Antonio-Aguirre Bani, Villarreal-Garza Cynthia, Perez-Ortiz Andric |
| Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast cancer research and treatment 2022 Apr . Hjorth Cathrine F, Damkier Per, Stage Tore B, Feddersen Søren, Hamilton-Dutoit Stephen, Rørth Mikael, Ejlertsen Bent, Lash Timothy L, Ahern Thomas P, Sørensen Henrik T, Cronin-Fenton Deird |
| Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
| Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
| Transporter Genes and statin-induced Hepatotoxicity. Cardiovascular drugs and therapy 2024 5 . Seo-A Choi, Jung Sun Kim, Yoon-A Park, Da Hoon Lee, Minju Park, Jeong Yee, Yoonkyung Chang, Tae-Jin Song, Hye Sun Gw |
| Obesity-Dependent Association of the rs10454142 PPP1R21 with Breast Cancer. Biomedicines 2024 4 12 (4): . Irina Ponomarenko, Konstantin Pasenov, Maria Churnosova, Inna Sorokina, Inna Aristova, Vladimir Churnosov, Marina Ponomarenko, Yuliya Reshetnikova, Evgeny Reshetnikov, Mikhail Churnos |
- Page last reviewed:Feb 1, 2024
- Content source: